Regent Pacific Limited 

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences companies in China, Europe, Hong Kong, and Taiwan. It operates in two segments, Biopharma and Corporate Investment. The company engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence (?AI?) systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.